Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cellular Diagnosis, Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02000999
What this trial is testing

Diagnosis of Bile Duct Strictures

Who this might be right for
Bile Duct StrictureCholangiocarcinomaPancreatic Cancer+1 more
Washington University School of Medicine 110
Not applicableStudy completedNCT01603004
What this trial is testing

Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Cancer
Memorial Sloan Kettering Cancer Center 25
Early research (Phase 1)Looking for participantsNCT07094204
What this trial is testing

Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Who this might be right for
Solid TumorNon-Small-Cell Lung CancerPancreatic Ductal Adenocarcinoma+1 more
Astellas Pharma Inc 364
Early research (Phase 1)Study completedNCT02231723
What this trial is testing

BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Sumitomo Pharma America, Inc. 139
Testing effectiveness (Phase 2)Study completedNCT02707159
What this trial is testing

Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Helse Stavanger HF 70
Early research (Phase 1)Ended earlyNCT06270082
What this trial is testing

Study of IK-595 in RAS- or RAF-altered Advanced Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Cancer+7 more
Ikena Oncology 75
Early research (Phase 1)Study completedNCT00325494
What this trial is testing

MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer

Who this might be right for
Pancreatic CancerMesotheliomaOvarian Cancer+1 more
Morphotek 24
Testing effectiveness (Phase 2)Looking for participantsNCT07480928
What this trial is testing

Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Unresectable Locally Advanced or Metastatic Disease
Beijing Biotech 42
Testing effectiveness (Phase 2)Ended earlyNCT03387098
What this trial is testing

QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Who this might be right for
Pancreatic Cancer
ImmunityBio, Inc. 4
Not applicableActive Not RecruitingNCT05708599
What this trial is testing

Compare Tissue and Liquid Biopsies in People With Different Types of Cancer

Who this might be right for
Non-Small-Cell Lung CarcinomaColorectal CancerPancreatic Ductal Adenocarcinoma
Boehringer Ingelheim 102
Testing effectiveness (Phase 2)Study completedNCT00005832
What this trial is testing

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 58
Early research (Phase 1)Study completedNCT02685553
What this trial is testing

Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project

Who this might be right for
Pancreatic Neuroendocrine TumorsClear Cell Renal CarcinomaSolid Pseudopapillary Tumors of the Pancreas
Universita di Verona 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Testing effectiveness (Phase 2)Study completedNCT05997056
What this trial is testing

Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

Who this might be right for
Neuroendocrine TumorsNETPancreatic Neuroendocrine Tumor+2 more
Aadi Bioscience, Inc. 12
Not applicableUnknownNCT05420259
What this trial is testing

Combined Exercise and Nutritional Intervention in GI Cancer Patients

Who this might be right for
Pancreatic CancerGastric CancerDiet+1 more
Hospital Beatriz Ângelo 68
Very early researchNot Yet RecruitingNCT07394205
What this trial is testing

Clinical Study of CBG131 CAR-T Cell Injection for the Treatment of CLDN18.2-Positive Advanced Gastric and Pancreatic Cancer

Who this might be right for
Advanced Gastric and Pancreatic Cancer
First Affiliated Hospital of Wenzhou Medical University 18
Testing effectiveness (Phase 2)Study completedNCT00002773
What this trial is testing

Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
St. Vincent Medical Center - Los Angeles
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Next Page